These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 23109881)

  • 1. Neuroprotection for stroke: current status and future perspectives.
    Minnerup J; Sutherland BA; Buchan AM; Kleinschnitz C
    Int J Mol Sci; 2012; 13(9):11753-11772. PubMed ID: 23109881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
    Sutherland BA; Minnerup J; Balami JS; Arba F; Buchan AM; Kleinschnitz C
    Int J Stroke; 2012 Jul; 7(5):407-18. PubMed ID: 22394615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
    Green AR; Ashwood T
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
    Savitz SI
    Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of new stroke therapies: outlook for neuroprotective drugs].
    Rogalewski A; Schäbitz WR
    Nervenarzt; 2008 Feb; 79(2):218-24. PubMed ID: 18214414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhuman primate models of stroke for translational neuroprotection research.
    Cook DJ; Tymianski M
    Neurotherapeutics; 2012 Apr; 9(2):371-9. PubMed ID: 22437447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era.
    Ginsberg MD
    Stroke; 2007 Jun; 38(6):1967-72. PubMed ID: 17478741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
    Schmidt A; Minnerup J; Kleinschnitz C
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quest for Quality in Translational Stroke Research-A New Dawn for Neuroprotection?
    Haupt M; Gerner ST; Bähr M; Doeppner TR
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2007 Feinberg lecture: a new road map for neuroprotection.
    Donnan GA
    Stroke; 2008 Jan; 39(1):242. PubMed ID: 18048866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
    Yamaguchi T; Sano K; Takakura K; Saito I; Shinohara Y; Asano T; Yasuhara H
    Stroke; 1998 Jan; 29(1):12-7. PubMed ID: 9445321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
    Wahlgren NG; Ahmed N
    Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.
    Carbone F; Teixeira PC; Braunersreuther V; Mach F; Vuilleumier N; Montecucco F
    Antioxid Redox Signal; 2015 Aug; 23(5):460-89. PubMed ID: 24635113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection for ischemic stroke: past, present and future.
    Ginsberg MD
    Neuropharmacology; 2008 Sep; 55(3):363-89. PubMed ID: 18308347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating Animal Models of Ischemic Stroke to the Human Condition.
    Matur AV; Candelario-Jalil E; Paul S; Karamyan VT; Lee JD; Pennypacker K; Fraser JF
    Transl Stroke Res; 2023 Dec; 14(6):842-853. PubMed ID: 36125734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in cerebral ischemia: emphasis on the SAINT trial.
    Chacon MR; Jensen MB; Sattin JA; Zivin JA
    Curr Cardiol Rep; 2008 Feb; 10(1):37-42. PubMed ID: 18416999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XI.
    Lyden P; Buchan A; Boltze J; Fisher M;
    Stroke; 2021 Aug; 52(9):3063-3071. PubMed ID: 34289707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.